title: Functional Cyp2e1 is required for substantial in vivo formation of 2,5-hexanedione from n-hexane in the mouse.
abstract: Neurotoxicity of n-hexane is mediated by its metabolite 2,5-hexanedione (2,5-HD). Cytochrome P4502E1 (CYP2E1) has been suggested but not shown to be involved in the formation of the metabolite. An objective of the current study was to assess the essentiality of CYP2E1 for in vivo 2,5-HD formation from n-hexane. This was accomplished by comparing urinary levels of the gamma-diketone in n-hexane-treated mice in which the Cyp2e1 gene has been deleted (Cyp2e1-/-) with that in n-hexane-treated wild-type (Cyp2e1+/+) mice. 2,5-HD was detectable not as the free compound but as further metabolites, at levels that were comparable in both strains of mice, following a daily 200 mg/kg i.p. dose of the alkane for 10 days. Continued daily n-hexane treatment resulted in increased urinary levels of 2,5-HD metabolites in Cyp2e1+/+ but not in Cyp2e1-/- mice. Only in Cyp2e1+/+ mice and only on day 21 of n-hexane treatment was a trace level of unchanged 2,5-HD detected. 3-Hexanol was the only other n-hexane metabolite detected in the mice but its concentration was higher in Cyp2e1-/- than in Cyp2e1+/+ mice. In n-hexane-treated rats, in contrast to mice, multiple metabolites of the alkane, including unchanged 2,5-HD, were detected. The results indicate that substantial in vivo formation of 2,5-HD from n-hexane in the mouse requires CYP2E1, and suggest that further detoxification of the metabolite may be very efficient in this species.
authors.affiliation: Department of Pharmacology and Toxicology, Rutgers Univeristy, Piscataway, NJ 08854, USA. iba@eohsi.rutgers.edu
authors.forename: M M
authors.initials: MM
authors.lastname: Iba
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: F J
authors.initials: FJ
authors.lastname: Gonzalez
mesh_terms: D000269:Adhesives / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000818:Animals; D001711:Biotransformation; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics / Q000378:metabolism*; D006586:Hexanes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000441:Hexanols / Q000652:urine; D006588:Hexanones / Q000652:urine*; D006720:Homozygote; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D018345:Mice, Knockout
chemical_list: D000269:Adhesives; D006586:Hexanes; D000441:Hexanols; D006588:Hexanones; C026385:n-hexane; C011269:2,5-hexanedione; D019392:Cytochrome P-450 CYP2E1